BioMARC

BioMARC

A non-profit biologics Contract Development & Manufacturing Organization owned & operated by Colorado State University

Founded 2006

Fort Collins, United States 37 employees Grant Total: $5.00M Biopharma, Manufacturing +2

BioMARC is a non-profit biologics Contract Development & Manufacturing Organization owned and operated by Colorado State University. The organization specializes in translating and producing biopharmaceutical products for non-clinical, clinical, and commercial use under Biosafety Level 3 (BSL-3) and BSL-2 containment (including spore former containment) and Select Agent (SA) biosecurity conditions. It also offers product and process development services, focused on implementation of cGMP regulations and scalability issues. With expertise in developing and optimizing product manufacturing processes and related tests, BioMARC has achieved notable milestones such as bringing a diagnostic parenteral product through clinical trials and commercial production, manufacturing a virus vaccine for a phase I clinical study, establishing master and working cell banks, developing and qualifying cell-based and analytical assays for product testing and release, and establishing a controlled process for manufacturing a therapeutic product for preclinical studies. Founded in 2014 and based in the United States, BioMARC received a $3.00M Grant investment on 28 February 2017. The organization's mission is to serve Colorado State University’s needs in research, service, and the translation of new discoveries into products with the aim of impacting the world at large. BioMARC leverages CSU's research expertise within the Infectious Disease Research Center and the greater CSU community, along with strategic partnerships to accelerate the development, manufacturing, and commercialization of biologic products, adhering to the highest quality and regulatory standards. This mission aligns well with CSU’s objectives in public service, economic development, and positive global impact.

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	$3.00M	-		28 Feb 2017
Grant	$2.00M	-		27 Oct 2014

Funding Stage

Amount

Investors

Lead Investors

Date

Grant

$3.00M

28 Feb 2017

Grant

$2.00M

27 Oct 2014

FAQ About BioMARC

A non-profit biologics Contract Development & Manufacturing Organization owned & operated by Colorado State University

BioMARC was founded in 2006.

BioMARC is headquartered in Fort Collins, United States.

BioMARC operates in Biopharma, Manufacturing, Pharmaceutical and Social Media. Its work centres on Biopharmaceutical Manufacturing, Contract Manufacturing Organization, Biologic Products and GMP Manufacturing.

BioMARC has approximately 37 employees.

BioMARC has completed 2 funding rounds, raising a total of $5.00M. The latest funding stage is Grant.

Top alternatives and competitors to BioMARC include JOINN Biologics US Inc., RedPharma Productie B.V., CMAB Biopharma, Pii (Pharmaceutics International, Inc.), EOC Pharma Group. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

BioMARC and JOINN Biologics US Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About BioMARC

Funding Rounds & Investors (2)

BioMARC Alternatives & Competitors

FAQ About BioMARC